Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US1638511089
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG005H82GB2
CC
Chemours Co
GICS: Materials · SECTOR: EQTY · SUB-SECTOR: Chemicals - Specialty
NAME
Chemours Co
ISIN
US1638511089
TICKER
CC
MIC
XNYS
REUTERS
CC.N
BLOOMBERG
CC US
Thu, 09.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 9, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchased...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.05.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - May 9, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgate...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 8, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchased...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 8, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Feb...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 6, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchased...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 06.05.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 6, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims agains...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 06.05.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - May 6, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgate...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 06.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 5, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Feb...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sun, 05.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 4, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Feb...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 04.05.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 4, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims agains...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Fri, 03.05.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - May 3, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgate...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.05.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - May 2, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between Feb...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.05.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - May 2, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgate...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 1, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purchased...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.05.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - May 1, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of The Chemours Company ("Chemours") (NYSE: CC) breached their fiduciary duties to Chemours and its shareholders. If you are...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 30.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 30, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 30.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 30, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 30.04.2024       Chemours
US1638511089

San Diego, California--(Newsfile Corp. - April 30, 2024) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of The Chemours Company (NYSE: CC) common stock have until this Monday, May 20, 2024 to seek appointment as lead plaintiff of the Chemours class action lawsuit. Captioned Taylor v. The Chemours Company, No. 1:24-cv...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 29.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 29, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sun, 28.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 28, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Sat, 27.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 27, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purcha...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 26.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 26, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 26.04.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - April 26, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims aga...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 25.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 25, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 25.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 25, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.04.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - April 24, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims aga...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 24, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purcha...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 24, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 23.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 23, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 22.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 22, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 22.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 22, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purcha...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 22.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 22, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sun, 21.04.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - April 21, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims aga...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sun, 21.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 20, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 20.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 19, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 19, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 18, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 18, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 17, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purcha...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 17, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 17.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 17, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 17.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 16, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 16.04.2024       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - April 16, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims aga...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 16.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 16, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the "Class Period"), of the important May 20, 2024 lead plaintiff deadline.SO WHAT: If you purcha...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 16.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 15, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.04.2024       Chemours
US1638511089

Los Angeles, California--(Newsfile Corp. - April 15, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulg...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.04.2024       Chemours
US1638511089

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - April 15, 2024) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC) for possible breaches of fiduciary duty and other violations of federal and state law.A securities fraud...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.04.2024       Chemours
US1638511089

Philadelphia, Pennsylvania--(Newsfile Corp. - April 15, 2024) - Kaskela Law LLC, a law firm dedicated exclusively to representing aggrieved investors in contingent litigation matters, announces that it is investigating The Chemours Company (NYSE: CC) ("Chemours") on behalf of the company's long-term shareholders.Recently a securities fraud complain...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.04.2024       Chemours
US1638511089

Radnor, Pennsylvania--(Newsfile Corp. - April 14, 2024) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that today the firm has filed a securities fraud class action lawsuit against The Chemours Company (NYSE: CC) ("Chemours" or the "Company") on behalf of investors who purchased or acquired Chemours common stock between...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sun, 14.04.2024       Chemours
US1638511089

New York, New York--(Newsfile Corp. - April 14, 2024) - Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink